{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-010817","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2022-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.475211+00:00","generated_at":"2026-06-26T04:12:29.918397+00:00","sec_items":["5.07"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Sema4 shareholders approve GeneDx acquisition, authorize share increase to 1B","bullets":["Stockholders approved shares for GeneDx acquisition: 178,157,301 for, 104,365 against.","Approved PIPE investment issuance: 178,106,518 for, 153,719 against.","Approved charter amendment increasing authorized Class A common from 380M to 1B shares.","Elected three Class I directors to serve three-year terms expiring 2025.","Ratified Ernst & Young as independent auditor for fiscal year 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-010817","json":"https://secwatch.observer/filing/0001628280-22-010817.json","markdown":"https://secwatch.observer/filing/0001628280-22-010817.md","text":"https://secwatch.observer/filing/0001628280-22-010817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000162828022010817/0001628280-22-010817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000162828022010817/smfr-20220427.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T04:12:29.918397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}